The QoL-Ma project develops medical e-health applications and solutions which collects and evaluates a population data in combination with screening procedures (in moment against Cervical Cancer (HPV screening) and a satellite-guided system. Primarily, the project focuses developing and emerging countries, but later developed countries should be included. It enables health care stake holders to interact with the persons of a screened population to provide screening information and education, to get feedback, to receive patient reported outcome (PRO data) and a better screening adherence resulting in an efficient prevention and treatment program. Furthermore, additional questions regarding specific cancer symptoms and socio-economic data enables to detect any disparities in the investigated population. With new technologies (telemedicine; logistics via geographic localization) we hope to support these underprivileged countries in health care.
Das QoL-Ma-Projekt entwickelt medizinische E-Health-Anwendungen und -Lösungen, die in Kombination mit Screening-Verfahren (zeitgleich mit Gebärmutterhalskrebs 'HPV-Screening') und einem satellitengestützten System Bevölkerungsdaten sammeln und auswerten. QoL-MA UG (haftungsbeschränkt) wird von EFRE (Europäischen Fonds für regionale Entwicklung) gefördert.
The App (Qol-Ma = Quality of Life Monitoring Application) is an e-Health application, which can be downloaded from the App Store. It is an innovative and unique combination of geo-stationary localization, registration, documentation, monitoring (MeQol) and education of participants (patients). It starts as a prototype with a prevention project against Cervical Cancer (Human Papilloma Virus (HPV) screening). In next steps, we will offer additional medical e-Health applications in important fields of medical issues having a high unmet need (e.g. Maternity, Cancer, metabolic diseases in emerging and developing countries).
The space technology behind this idea is Global Navigation Satellite Systems (GNSS) such as the Global Positioning Systems (GPS) and in future also Galileo. Positioning technology shall be used to determine a person’s location coordinates which in turn make up the patient digital address. By attaching location information to user profiles, we’re able to offer a myriad of value added services i.e. last-mile healthcare delivery to off-grid rural areas. A planned joint venture with a drone manufacturer in Germany will enable us to perform delivery of critical life-saving medical supplies via Unmanned Aerial Vehicle (UAV). Furthermore, the QoL-Ma system uses Satellite Communication to facilitate video conferencing and data transmission from remote/ mobile health centers with poor Internet infrastructure.